Weight loss has always been big business, but it’s exploded of late due to surging demand for Ozempic, Wegovy and other new diabetes and obesity drugs. In the first half …
Most analysts predict the market for new weight loss drugs such as Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. …
Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019. Alex Flynn | Bloomberg | Getty Images …
After a rough September, October has so far been much more kind to stocks and has helped Wall Street cut into some of its third-quarter losses . More encouragingly, our …
Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News medical contributor, believes fresh data from Novo Nordisk on Ozempic’s …
A LVMH Moet Hennessy Louis Vuitton SE store in Shanghai, China on Wednesday, June 14, 2023. Bloomberg | Bloomberg | Getty Images Shares of LVMH dropped to their lowest level …
A box of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk. George Frey | Reuters Check out the companies making big moves midday. …
Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history — thanks to its newfound success with two products: Ozempic and Wegovy. The drugs are once-weekly injectables …
My top 10 things to watch Friday, Oct. 6 1. U.S. stock futures are under pressure Friday morning, with the S & P 500 falling nearly 1% on the back …
September, historically the worst month of the year for stocks, once again brought pain to Wall Street, sending the market lower for the third quarter. A steep rise in Treasury …